Published in J Clin Oncol on March 01, 1999
Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients. World J Surg (2007) 1.66
Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol (2012) 1.07
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions. J Cell Mol Med (2011) 0.98
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer. World J Surg Oncol (2004) 0.98
Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival. Radiology (2010) 0.97
Brain metastases from ovarian carcinoma. ISRN Oncol (2011) 0.96
Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy. J Transl Med (2011) 0.84
Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a 2-cohort, phase 2 study. Cancer (2011) 0.83
The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma. World J Surg (2011) 0.82
Clinical course of stage IV epithelial ovarian cancer. J Clin Oncol (1999) 0.81
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study. Indian J Med Paediatr Oncol (2015) 0.80
Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery. J Gynecol Oncol (2011) 0.76
Identifying clinical improvement in consolidation single-arm phase 2 trials in patients with ovarian cancer in second or greater clinical remission. Int J Gynecol Cancer (2012) 0.75
Primary ovarian serous adenocarcinoma with ipsilateral axillary lymph node metastasis: a case report. Indian J Surg Oncol (2014) 0.75
Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma. Gynecol Oncol Rep (2016) 0.75
Central nervous system metastasis in epithelial ovarian carcinoma: a case report and literature review. J Family Reprod Health (2015) 0.75
Optimal cytoreduction in stage IV ovarian carcinoma. J Clin Oncol (1999) 0.75
In Pursuit of Optimal Cytoreduction in Ovarian Cancer Patients: The Role of Surgery and Surgeon. J Obstet Gynaecol India (2016) 0.75
Fine structure constant defines visual transparency of graphene. Science (2008) 9.06
Detection of individual gas molecules adsorbed on graphene. Nat Mater (2007) 8.00
Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol (1989) 6.86
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med (1995) 6.71
Control of graphene's properties by reversible hydrogenation: evidence for graphane. Science (2009) 5.70
U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol (2002) 4.92
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A (1999) 4.52
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol (2001) 4.45
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet (2001) 4.16
The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother (1986) 3.94
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65
UK guidelines for the management of cutaneous melanoma. Br J Plast Surg (2002) 3.51
Psychological effects of being offered choice of surgery for breast cancer. BMJ (1994) 3.48
Drip breast milk: it's composition, collection and pasteurization. Early Hum Dev (1977) 3.47
Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab (1995) 3.34
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
Outbreaks of Salmonella enteritidis infections in the United States, 1985-1991. J Infect Dis (1994) 2.94
Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet (1990) 2.77
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74
Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol (2000) 2.67
Infectious complications of subcutaneous interleukin-2 and interferon-alpha. Lancet (1992) 2.65
The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J (1990) 2.57
Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol (1992) 2.54
Isolation of a polymorphic DNA segment unique to human chromosome 7 by molecular cloning of hybrid cell DNA. Mol Gen Genet (1983) 2.43
FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet (1999) 2.36
Imaging features of retroperitoneal and pelvic schwannomas. Clin Radiol (2005) 2.32
Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital. BJU Int (2003) 2.29
A breakdown of symmetry in the folding transition state of protein L. J Mol Biol (2000) 2.26
Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities. Br J Dermatol (2012) 2.23
Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol (2010) 2.22
Glove perforations during open surgery for gynaecological malignancies. BJOG (2008) 2.17
Modified staging system for extremity soft tissue sarcomas. Ann Surg Oncol (1999) 2.16
Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J (1995) 2.14
Management of metastatic melanoma during pregnancy. BMJ (1998) 2.10
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene (1994) 2.05
A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996-7. Epidemiol Infect (2002) 2.03
Ovarian cancers related to minimal access surgery. Br J Obstet Gynaecol (1995) 2.02
Bio-Electric Correlates of Human Ovulation. Yale J Biol Med (1937) 1.97
A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc Natl Acad Sci U S A (1991) 1.97
The acquisition of the voicing contrast in English: study of voice onset time in word-initial stop consonants. J Child Lang (1980) 1.95
Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol (1993) 1.93
Escherichia coli O157:H7 outbreak associated with an improperly chlorinated swimming pool. Clin Infect Dis (1999) 1.84
Curcumin is an in vivo inhibitor of angiogenesis. Mol Med (1998) 1.81
Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet (1992) 1.81
Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol (1996) 1.78
Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol (2008) 1.76
Accident & Emergency Department's response to patients' inquiries by telephone. J R Soc Med (1991) 1.74
Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg (2005) 1.71
Aggressive angiomyxoma. A report of four cases occurring in men. Am J Surg Pathol (1992) 1.69
A genetic association for cigarette smoking behavior. Health Psychol (1999) 1.69
Breast diseases: color Doppler US in differential diagnosis. Radiology (1993) 1.67
Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer (1993) 1.67
Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol (2005) 1.66
Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res (1989) 1.64
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer (2008) 1.62
Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol (1999) 1.60
Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ (1989) 1.59
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). Ann Oncol (2005) 1.58
Use and effectiveness of hypothermia blankets for febrile patients in the intensive care unit. Clin Infect Dis (1997) 1.57
Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene (1990) 1.56
Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts. Am J Epidemiol (2001) 1.55
Influence of cholecystectomy on symptoms. Br J Surg (1991) 1.54
Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol (1997) 1.54
Myofibrosarcoma: a clinicopathologic study. Am J Surg Pathol (2001) 1.54
Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol (1998) 1.53
Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck. Ann Oncol (1997) 1.53
The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol (1994) 1.53
Gastric carcinoma presenting with testicular metastasis. Br J Urol (1994) 1.52
Prognostic index for extremity soft tissue sarcomas with isolated local recurrence. Ann Surg Oncol (2001) 1.52
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring. Cancer (1995) 1.52
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial. J Clin Oncol (1985) 1.51
Nipple confusion--who is confused? J Pediatr (1996) 1.50
Clinical outcomes of extra-thoracic solitary fibrous tumours. Eur J Surg Oncol (2009) 1.50
FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet (1999) 1.49
Detection of chlamydiosis in a shipment of pet birds, leading to recognition of an outbreak of clinically mild psittacosis in humans. Clin Infect Dis (1998) 1.49
Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Radiother Oncol (2001) 1.49
Indolent cutaneous prodrome of fatal HTLV-I infection. Lancet (1990) 1.48
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett (1995) 1.48
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer. J Clin Oncol (1987) 1.47
Hormone replacement therapy and survival after surgery for ovarian cancer. BMJ (1991) 1.46
Head and neck liposarcoma. Cancer (1995) 1.45
Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med (1997) 1.44
Real-time DNA binding measurements of the ETS1 recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms. Protein Sci (1994) 1.44
Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int (2000) 1.44
Electronic properties of graphene encapsulated with different two-dimensional atomic crystals. Nano Lett (2014) 1.43
Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults. Eur J Endocrinol (1997) 1.43
Reducing time in bed after cardiac catheterization (TIBS II) Am J Crit Care (1996) 1.43
Mammographic accuracy and patient age: a study of 297 patients undergoing breast biopsy. Clin Radiol (1993) 1.40
Formation of chloroethylamine and 1,3-oxazolidine-2-one following ifosfamide administration in humans. Drug Metab Dispos (1995) 1.39
Tooth induction in chick epithelium: expression of quiescent genes for enamel synthesis. Science (1980) 1.39
Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy? Clin Nutr (2005) 1.39